drugset / Trial / NCT02957266

Cervical Cancer Radiotherapy by Use of VMAT, Individualized Polyradiosensitization and Interstitial Brachytherapy

NCT02957266 ↗

Phase 3 Unknown 400 enrolled The National Center of Oncology, Azerbaijan
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to define an effectiveness of concurrent chemoradiotherapy of cervical cancer patients treated by VMAT (volumetric arc therapy) based external beam radiotherapy, polyradiosensitization by cisplatin and gemcitabine and interstitial brachytherapy.

Timeline

Start
2015-03
Primary completion
2018-12
Completion
2020-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Gemcitabine Small molecule — —
Background Cisplatin Other / unclassified — —

Indications